BeOne Medicines (ONC) Net Margin (2016 - 2025)
Historic Net Margin for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to 8.84%.
- BeOne Medicines' Net Margin rose 209600.0% to 8.84% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.38%, marking a year-over-year increase of 273200.0%. This contributed to the annual value of 16.92% for FY2024, which is 189400.0% up from last year.
- Per BeOne Medicines' latest filing, its Net Margin stood at 8.84% for Q3 2025, which was up 209600.0% from 7.17% recorded in Q2 2025.
- BeOne Medicines' 5-year Net Margin high stood at 27.57% for Q3 2023, and its period low was 320.24% during Q2 2021.
- Its 5-year average for Net Margin is 83.9%, with a median of 57.94% in 2023.
- Per our database at Business Quant, BeOne Medicines' Net Margin skyrocketed by 7405000bps in 2021 and then tumbled by -1529100bps in 2022.
- BeOne Medicines' Net Margin (Quarter) stood at 276.04% in 2021, then soared by 58bps to 117.16% in 2022, then skyrocketed by 51bps to 57.94% in 2023, then soared by 77bps to 13.47% in 2024, then surged by 166bps to 8.84% in 2025.
- Its Net Margin was 8.84% in Q3 2025, compared to 7.17% in Q2 2025 and 0.11% in Q1 2025.